We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Maria Abreu

Maria T. Abreu MD

Professor of Medicine; Professor of Microbiology and Immunology; Vice Chair of Research, Department of Medicine; Martin Kalser Chair in Gastroenterology; Director, Crohn’s & Colitis Center, University of Miami Miller School of Medicine, Miami, Florida

Dr. Maria T. Abreu is a gastroenterologist who specializes in inflammatory bowel disease (IBD). She completed her medical degree at the University of Miami, Miller School of Medicine. Her postdoctoral training included an internship and residency in medicine at the Brigham and Women’s Hospital in Boston, Massachusetts and a clinical and research fellowship in gastroenterology at the University of California, Los Angeles (UCLA). She was an Associate Professor of Medicine with Mount Sinai School of Medicine, NYC and head of the IBD Center. She is currently the Director of the Crohn’s and Colitis Center, Professor of Medicine and Professor of Microbiology and Immunology at the University of Miami Miller School of Medicine. Dr. Abreu was honored in April 2018, with the Provost’s Award for Scholarly Activity. She was appointed in June 2018 to serve as the Vice Chair of Research for the Department of Medicine.

Dr. Abreu has more than 20 years of leadership experience in basic, translational and clinical research and mentoring. She is a nationally and internationally renowned physician-scientist in IBD. Dr. Abreu was elected to the American Society for Clinical Investigation in 2010 and in 2018 to the Association of American Physicians (AAP); both are honor societies for physician-scientists. She holds key positions with several professional societies. She is the immediate past Council Chair of the American Gastroenterological Association (AGA) Institute Council. Her most recent appointment is as the Deputy Chair of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD), where she will serve as Chairperson starting in 2019. Also, in 2019, she has been recognized as a new Councillor-at-Large member of the American Gastroenterological Association (AGA) Governing Board for a term of three years.

In March, 2018, Dr. Abreu was recognized by the CCF (Crohn’s & Colitis Foundation) by presentation of the Honorary Book of Hope Award presented at the 28th annual Book of Hope CCF Luncheon. She is proud to have received the 2016 Minority Digestive Health Care Award for her commitment to helping minority trainees and researching GI health issues in minority populations. Dr. Abreu is a recipient of a 2019 Sherman Prize by The Bruce and Cynthia Sherman Charitable Foundation that recognizes outstanding achievements in IBD.

Dr. Abreu is frequently invited as a speaker (in English and Spanish) at CME-accredited seminars and symposia on basic science and clinical topics all over the world. As an educator, Dr. Abreu is regularly asked to speak at national and international symposia. She has authored more than 100 peer-reviewed articles, books, chapters and reviews. Additionally, she has served as an editorial board member for Inflammatory Bowel Diseases and Gastroenterology & Hepatology News; former editor for the Journal of Immunology; former Associate Editor of Journal of Crohn’s & Colitis and ongoing as a reviewer for several other prestigious journals. Dr. Abreu is a frequent speaker at national and international symposia on basic science and clinical topics.

Disclosures

Dr. Abreu receives grant/research support from: Prometheus Laboratories, Takeda, and Pfizer. She is a consultant for: Abbvie, Eli Lilly, Janssen, Takeda, Focus Medical Communications, Boehringer Ingelheim Pharmaceuticals, Gilead, Imedex, Cornerstone Health, Inc., and Landos Biophama.